J Thiery|D Seidel - JoVE Visualize

Showing results (31-40 of 419) with videos related to

Pageof 42

Sort By:

Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997

Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and CD Halevy, J Thiery, D Nagel, et al.

ASAIO Transactions|July 1, 1989

Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemiaT Eisenhauer, V W Armstrong, P Schuff-Werner, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1991

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigationH G Fieseler, V W Armstrong, E Wieland, et al.

Circulation|October 7, 1997

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trialK Wenke, B Meiser, J Thiery, et al.

Atherosclerosis|March 1, 1996

Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbitsJ Thiery, D Teupser, A K Walli, et al.

ASAIO Transactions|July 1, 1991

Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experienceT Eisenhauer, U Müller, P Schuff-Werner, et al.

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999

Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patientsB R Jaeger, J Schirmer, J Thiery, et al.

Biochimica Et Biophysica Acta|December 30, 1994

Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membraneB Engelmann, C Bräutigam, R Kulschar, et al.

Arzneimittel-Forschung|March 1, 1990

[Maximal treatment of hypercholesteremia: what is possible?]J Thiery

Clinical and Experimental Pharmacology & Physiology|December 11, 2007

CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart diseaseD Teupser, M A Mueller, J Koglin, et al.

Pageof 42

Showing results (31-40 of 419) with videos related to

Sort By:

Pageof 42

Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1997

Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and CD Halevy, J Thiery, D Nagel, et al.

ASAIO Transactions|July 1, 1989

Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemiaT Eisenhauer, V W Armstrong, P Schuff-Werner, et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry|December 31, 1991

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigationH G Fieseler, V W Armstrong, E Wieland, et al.

Circulation|October 7, 1997

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trialK Wenke, B Meiser, J Thiery, et al.

Atherosclerosis|March 1, 1996

Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbitsJ Thiery, D Teupser, A K Walli, et al.

ASAIO Transactions|July 1, 1991

Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experienceT Eisenhauer, U Müller, P Schuff-Werner, et al.

Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999

Coronary risk factor management for the prevention and treatment of graft vessel disease in heart transplant patientsB R Jaeger, J Schirmer, J Thiery, et al.

Biochimica Et Biophysica Acta|December 30, 1994

Reversible reduction of phospholipid bound arachidonic acid after low density lipoprotein apheresis. Evidence for rapid incorporation of plasmalogen phosphatidylethanolamine into the red blood cell membraneB Engelmann, C Bräutigam, R Kulschar, et al.

Arzneimittel-Forschung|March 1, 1990

[Maximal treatment of hypercholesteremia: what is possible?]J Thiery

Clinical and Experimental Pharmacology & Physiology|December 11, 2007

CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart diseaseD Teupser, M A Mueller, J Koglin, et al.

Pageof 42